Congenital factor XII deficiency
MONDO:0009315Congenital factor XII deficiency is an autosomal recessive systemic dysfunction of the hemostatic pathway, that is due to a defect in the coagulation factor XII (FXII or Hageman factor), and is either asymptomatic or characterized by a prolonged activated partial thromboplastin time and an increased risk for thromboembolism. FXII deficiency is strongly associated with primary recurrent abortions.
Also known as: Factor XII Deficiency, Hageman Factor deficiency, congenital Hageman factor deficiency, congenital factor XII deficiency, F12 deficiency, Haf deficiency, coagulation factor 12 deficiency, factor 12 deficiency
14 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
Could a clotting booster cut blood loss in ICU patients?
Disease control Recruiting nowThis study looks at whether adding a drug called Wilate (a von Willebrand factor concentrate) to standard platelet transfusions can reduce bleeding and the need for more blood products in intensive care patients. About 120 adults who need platelets during or after surgery will be…
Phase: PHASE4 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
Hormonal showdown: which treatment tames heavy periods in bleeding disorders?
Disease control Recruiting nowThis study follows 300 teens and young adults (ages 10-24) with inherited bleeding disorders who choose either a levonorgestrel IUD or norethindrone acetate pills for heavy menstrual bleeding. Researchers will track bleeding patterns, satisfaction, and quality of life over six mo…
Sponsor: Oregon Health and Science University • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
New model aims to decode mysterious blood test results
Knowledge-focused Recruiting nowThis study is checking if a computer model can accurately predict why some people have a prolonged blood clotting time (APTT). The model uses data from routine blood tests to tell if the cause is harmless or a sign of a clotting disorder. Researchers will test it on 1,500 patient…
Sponsor: Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz • Aim: Knowledge-focused
Last updated Aug 15, 2026 00:00 UTC
-
Massive study to track Real-World safety of new blood disorder drugs
Knowledge-focused Recruiting nowThis study is collecting long-term safety and effectiveness data on treatments for various blood disorders, including hemophilia, sickle cell disease, and clotting disorders. It aims to enroll 3000 people of any age with these conditions. Researchers will monitor side effects, co…
Sponsor: American Thrombosis and Hemostasis Network • Aim: Knowledge-focused
Last updated Jul 15, 2026 00:00 UTC
-
Can hormones tame heavy periods in teens with bleeding disorders? new study aims to find out.
Knowledge-focused Recruiting nowThis study follows 163 teens and young adults with heavy menstrual bleeding, some with a bleeding disorder and some without, to see how well hormonal treatments like the pill, patch, or IUD work. Researchers will measure blood loss, quality of life, and iron levels over time. The…
Sponsor: University Hospital, Geneva • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Massive blood disorder registry aims to transform care
Knowledge-focused Recruiting nowThis study is a large registry that collects health information from up to 200,000 people with blood disorders such as hemophilia, thrombosis, and sickle cell disease. Participants are seen at Hemophilia Treatment Centers across the U.S. The goal is to gather real-world data to h…
Sponsor: American Thrombosis and Hemostasis Network • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
New study tracks joint replacement success in bleeding disorder patients
Knowledge-focused Recruiting nowThis study looks at how well hip, knee, shoulder, and other joint replacement surgeries work in adults with inherited bleeding disorders like hemophilia. Researchers will collect information from medical records and follow patients over time to understand risks, complications, an…
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New registry aims to uncover dengue risks for bleeding disorder patients
Knowledge-focused Recruiting nowThis study creates a registry to collect data on dengue infections in people with congenital bleeding disorders like hemophilia. Dengue can cause serious bleeding, and those with bleeding disorders may face higher risks. The goal is to understand bleeding complications, treatment…
Sponsor: Mahidol University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:06 UTC
-
Could low serotonin in blood platelets be a hidden cause of bleeding?
Knowledge-focused Recruiting nowThis study looks at 50 adults with unexplained bleeding to see if low serotonin levels in their platelets are linked to their symptoms. Researchers will use a standard bleeding questionnaire to measure bleeding severity. The goal is to better understand how serotonin deficiencies…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Scientists dig into genetic roots of rare bleeding disorders
Knowledge-focused Recruiting nowThis study looks at how blood cells interact and what goes wrong in inherited bleeding disorders like Glanzmann thrombasthenia. Researchers will analyze blood samples from up to 60 healthy volunteers and patients to find genetic defects. The goal is to better understand these con…
Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC